Healthcare, Medical Devices & Biotechnology | Extrapolate’s Post

#In_Vitro_Fertilization_Market - Global Industry Assessment & Forecast https://lnkd.in/d-hxaSb6 #IVF #InVitroFertilization #FertilityTreatment #AssistedReproduction #IVFSuccess #FertilityClinic #ReproductiveHealth #InfertilitySolutions #IVFJourney #FertilityAwareness #MedicalAdvancements #MarketResearch #MarketAnalysis #ConsumerTrends #MarketIntelligence #BusinessStrategy #IndustryTrends #MarketReports #ResearchAndDevelopment

The IVF market is projected to grow at a robust rate of 9% by 2029. For more detailed insights, get your sample report here: https://lnkd.in/dxBNGQf4 Several factors are driving this growth, including: 👉Increasing median age of first-time mothers 👉Technological advancements in IVF devices 👉Growing IVF tourism 👉Rising number of fertility clinics worldwide 👉Declining fertility rates 👉Increasing cases of male infertility 👉Favorable funding environment Leading players in this market include CooperCompanies, Vitrolife, Thermo Fisher Scientific, Esco Medical, IVFtech ApS, FUJIFILM Irvine Scientific, Kitazato, FertiPro N.V., Gynotech Ltd., and more.

🔬 World’s first live birth using eggs matured outside the body successful In a world-first, a live human birth that used an ovarian support cell (OSC) technology that matures eggs outside the body has been successful. Unlike traditional IVF methods, which rely on 10 to 14 days of high-dose hormonal stimulation to mature eggs, this new method – named Fertilo – uses engineered, young ovarian support cells to recreate the natural egg maturation process in a laboratory setting. This process replaces 80% of hormone injections required with traditional IVF, and reduces the duration of treatment cycles to just three days, offering patients a more comfortable and less invasive experience. 💬 Dr Dina Radenkovic Turner, CEO and co-founder of Gameto which has developed the technology, said: “By overcoming the major challenges of conventional IVF, such as long treatment cycles, significant side effects, and the emotional and physical strain, Fertilo provides a potentially faster, safer, and more accessible solution for families. "This milestone marks a turning point in reproductive health and highlights the first application of iPSC technology in IVF and the immense potential of our technology.” Read more: https://lnkd.in/eE-uwWbB #womenshealth #womenshealthmatters #femtech #healthtech #genderhealthgap #research #innovation #healthequity #gynaecology #reproductivehealth #equalities #healthinequalities #women #medtech

Fertilo is a fertility method that uses stem cells to mature human eggs outside the body — and the first baby conceived using this method was just born: The first baby conceived using a revolutionary fertility method known as Fertilo has been born at the Santa Isabel Clinic in Lima, Peru. Developed by Gameto, a female-led biotech company, the Fertilo technique uses ovarian support cells (OSCs) derived from induced pluripotent stem cells (iPSCs) to mimic the natural egg maturation process outside the body. Unlike traditional IVF, Fertilo avoids 80% of the hormone injections and reduces the treatment cycle duration to just three days, making it faster, safer, and less invasive. Gameto’s CEO, Dr. Dina Radenkovic, hailed the achievement as a “turning point in reproductive health,” emphasizing how the method alleviates physical and emotional strain often associated with conventional IVF. The Fertilo technique has already gained regulatory approval in several countries, including Australia, Japan, and Mexico, with plans for Phase 3 trials in the US. For the mother of the first Fertilo baby, the innovative approach made the journey to parenthood less stressful and more accessible, offering hope to millions of families worldwide.

The rapid growth of the IVF (In Vitro Fertilization) industry can be attributed to several factors: 👶 Increasing Infertility Rates: Infertility rates have been rising globally due to factors such as delayed childbearing, lifestyle changes, and environmental factors. More people are seeking fertility treatments like IVF to conceive. 👶 Advancements in Technology: IVF techniques have significantly improved over the years, making the procedure more effective and accessible. Innovations such as ICSI (Intracytoplasmic Sperm Injection), preimplantation genetic testing, and frozen embryo transfer have boosted success rates and expanded the range of patients who can benefit from IVF. 👶 Growing Acceptance and Awareness: IVF and assisted reproductive technologies (ART) are becoming more accepted and understood by the public. Increased awareness through media, celebrities sharing their experiences, and advocacy groups have reduced stigma and encouraged more people to consider IVF as an option. 👶 Changing Social Norms: Cultural shifts such as increasing acceptance of single-parent families, same-sex couples, and older parents have also driven demand for IVF services, as these groups may require assistance to conceive. 👶 Regulatory Environment: Many countries have developed regulatory frameworks that support IVF accessibility and safety. Clear guidelines and regulations have fostered growth in the industry while ensuring patient safety and ethical practices. 👶 Medical Tourism: The availability of IVF treatments at more affordable prices in certain countries has led to a rise in medical tourism for fertility services. This has expanded the market and encouraged competition and innovation. 👶 Insurance Coverage: In some regions, expanded insurance coverage for fertility treatments has made IVF more financially feasible for a larger portion of the population, thus increasing demand. 👶 Success Rates: As success rates of IVF have improved, more individuals and couples are willing to invest in this treatment option. Success stories and testimonials contribute to the growing interest and trust in IVF clinics. 👶 Delay in Childbearing: With more people choosing to delay starting families due to career or personal reasons, there is a higher demand for fertility treatments later in life, which often involves IVF. Overall, the combination of technological advancements, changing societal attitudes, and increasing infertility rates has fueled the rapid growth of the IVF industry. Continued research and development in reproductive medicine are likely to further expand its reach and effectiveness in the future. #IVF #IVFIndia #gynecologist 

"Exploring the Future of IVF in Australia: Unique Trends Shaping the Market in 2024" 𝐌𝐚𝐫𝐤𝐞𝐭 𝐕𝐚𝐥𝐮𝐞 : The Australian IVF Services Market was valued at USD 526.82 million in 2023 and is projected to grow at a CAGR of 3.5% from 2023 to 2030, reaching approximately USD 670.26 million by 2030. 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰 : The in-depth analysis of the Australian IVF Services market highlights key factors shaping the industry, including regulatory, financial, and ethical aspects. Despite limited public funding, private IVF clinics are thriving due to rising demand, creating opportunities for growth, mergers, and acquisitions. 𝑪𝒍𝒊𝒄𝒌 𝒉𝒆𝒓𝒆 𝒇𝒐𝒓 𝒇𝒓𝒆𝒆 𝒔𝒂𝒎𝒑𝒍𝒆 + 𝒓𝒆𝒍𝒂𝒕𝒆𝒅 𝒈𝒓𝒂𝒑𝒉𝒔 𝒐𝒇 𝒕𝒉𝒆 𝒓𝒆𝒑𝒐𝒓𝒕:  https://lnkd.in/dwybxqjR 𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐲𝐧𝐚𝐦𝐢𝐜𝐬 : The dynamics of the Australian IVF Services market are shaped by a combination of rising demand, limited public funding, and growing technological advancements. With increasing awareness around fertility options, more patients are seeking treatments like genetic testing, egg freezing, and pre-implantation genetic diagnosis (PGD). 𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬 : The Australian IVF Services market is experiencing key trends driven by technological advancements, shifting patient preferences, and evolving healthcare policies. Fertility treatments such as egg freezing, genetic testing, and pre-implantation genetic diagnosis (PGD) are gaining popularity, reflecting a growing demand for personalized and advanced reproductive options. 𝑼𝒏𝒍𝒐𝒄𝒌 𝒚𝒐𝒖𝒓 𝒆𝒙𝒄𝒍𝒖𝒔𝒊𝒗𝒆 𝑷𝑫𝑭 𝒏𝒐𝒘!  https://lnkd.in/dA3keqxg 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐠𝐢𝐨𝐧 : The Australian IVF Services market is characterized by regional variations, with major hubs of fertility treatment concentrated in metropolitan areas such as Sydney, Melbourne, and Brisbane. These regions see the highest demand due to greater access to advanced technologies, specialized clinics, and comprehensive fertility services. 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 : Virtus Health Monash IVF Group IVF Australia Genea #AustraliaIVF #IVFServices #FertilityCare #FertilityAustralia #IVFMarket #IVFTrends #FertilityJourney #ReproductiveHealth #IVFInnovation #EggFreezing #GeneticTesting #FertilityTreatment #AustralianHealthcare #IVFClinics #FertilityAwareness #PreimplantationGeneticTesting #PGD

𝗝𝗮𝗽𝗮𝗻 𝗜𝗻 𝗩𝗶𝘁𝗿𝗼 𝗙𝗲𝗿𝘁𝗶𝗹𝗶𝘇𝗮𝘁𝗶𝗼𝗻 (𝗜𝗩𝗙) 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟰-𝟮𝟬𝟯𝟬. 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 *𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙: https://lnkd.in/dAwvQQq4 In Vitro Fertilization (IVF) is a specialized medical process that helps couples facing difficulties in conceiving naturally. The procedure involves administering hormonal medications to stimulate the ovaries to produce multiple eggs, which are then retrieved and fertilized with sperm in a controlled laboratory environment. The resulting embryos are monitored closely, and one or more healthy embryos are selected and transferred into the woman's uterus for implantation. The chances of pregnancy decrease after the age of 32, with a further reduction by age 40. The average age at which women are conceiving for the first time is rising, leading to various pregnancy complications and increased infertility risks. Factors such as delayed marriage, career prioritization over family planning, and economic instability are contributing to this trend, driving the adoption of IVF treatments globally. These trends are contributing to the growth of the IVF market in Japan during the forecast period. *𝗕𝘆 𝗣𝗿𝗼𝗱𝘂𝗰𝘁: Reagent, Cryopreservation Medium, Embryo Culture Medium, Egg Treatment Medium, Sperm Processing Medium, Device, Imaging System, Incubator, Freezing System, IVF Cabinet, Egg Suction Pump, Sperm Separation System, Micromanipulator System, Others, Accessories *𝗕𝘆 𝗣𝗿𝗼𝗰𝗲𝗱𝘂𝗿𝗲 𝗧𝘆𝗽𝗲: Fresh donor, Frozen donors, Fresh non-donor, Frozen non-donor *𝗕𝘆 𝗖𝘆𝗰𝗹𝗲 𝗧𝘆𝗽𝗲: Conventional IVF, ICSI-IVF, IVF with donor eggs *𝗕𝘆 𝗘𝗻𝗱 𝘂𝘀𝗲𝗿: Infertility Clinic, Hospital, Others *𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: Boston IVF, Monash IVF Group, Pelargos IVF, Ovation Fertility, Shady Grove Fertility, Bangkok IVF Center, Bloom IVF #JapanIVF #InVitroFertilization #IVFJapan #ReproductiveHealth #FertilityTreatment #AssistedReproductiveTechnology #FertilitySolutions #JapanFertility #IVFMarket #InfertilityTreatment #JapanHealthcare #FertilityCare #FamilyPlanning #MedicalTourism #JapanHealthcareIndustry #WomenHealth #ReproductiveMedicine #FertilityTrends #PregnancyComplications #JapanMedicalInnovation

Gameto has announced the world’s first live human birth using Fertilo, an ovarian support cell (OSC) technology that matures eggs outside the body. The delivery was conducted at Santa Isabel Clinic, in Lima, Peru. This could represent a huge step forward in fertility management. Traditional methods rely on the mother undergoing 10–14 days of high-dose hormonal stimulation, via injections, to mature eggs. Instead, Fertilo uses engineered, young ovarian support cells to recreate the natural egg maturation process in a laboratory setting. This process replaces 80% of hormone injections required with traditional IVF, and reduces the duration of treatment cycles to just three days. “We are delighted to celebrate the world’s first live birth conceived using Fertilo,” said Dina Radenkovic, MD, CEO and co-founder of Gameto. “By overcoming the major challenges of conventional IVF, such as long treatment cycles, significant side effects, and the emotional and physical strain, Fertilo provides a potentially faster, safer, and more accessible solution for families. This milestone marks a turning point in reproductive health and highlights the first application of iPSC technology in IVF and the immense potential of our technology.”